STRAD Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of STRAD Antibodies for advanced research in cellular signaling and development. STRAD Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). STRAD (Ste20-related adapter protein) plays a crucial role in regulating the activity of the LKB1 tumor suppressor, which is essential for maintaining cellular energy homeostasis and regulating cell growth. The proper functioning of STRAD is vital for various physiological processes, including cell proliferation and differentiation, making it an important target for cancer research and therapeutic development. STRAD monoclonal antibodies enable researchers to investigate protein-protein interactions and signaling pathways involved in cellular metabolism. Researchers can utilize STRAD monoclonal antibodies to examine expression patterns across different tissue types and cellular compartments. Understanding STRAD's role in cellular processes can lead to potential breakthroughs in cancer treatment strategies. Santa Cruz Biotechnology monoclonal antibodies for STRAD research support scientists worldwide in advancing our understanding of cellular signaling pathways and their impact on human health.